BST2 and cancer: Induction of BST-2 in macrophages with the BST-2 agonist, IFNα,12 results in increased adherence of cancer cells expressing the different variants of BST-2 to IFNα+ macrophages compared with IFNα- macrophages (Figure 2i, white and gray backgrounds).